Enanta Pharmaceuticals remains a Buy as zelicapavir shows promise in RSV trials; strong financials support growth. Read why ENTA stock remains a Buy.

New data uncovers why so many men continue to avoid addressing their mental health struggles, despite rising awareness and ...

Eli Lilly's GLP-1 Pill Just Beat Out Novo Nordisk's in a Test. Here's 1 Thing Investors Need to Know. The secondary endpoints ...

As health-care workers around the world will attest, infections are extremely common in children in primary care and ...

Zohran Mamdani’s upstart campaign for mayor of New York City is inspiring the growing South Asian community to be more active ...

Thousands of learners in primary schools across the country risk being left out of crucial government support after 3,485 ...

The ruling in the Google antitrust trial has led to a host of hard-to-answer questions about the future of Google's search ...

A 3-year review of metrics related to primary care delivery for Medicare-eligible patients suggests that payment models that ...

ABU DHABI, 10th September, 2025 (WAM) -- ne’ma - the National Food Loss and Waste Initiative - in collaboration with the Federal Competitiveness and Statistics Centre (FCSC) and local statistics ...

California Governor Gavin Newsom is showing some early strength in a hypothetical 2028 Democratic primary, but his lead is limited, according to polling. According to data from Race to the White House ...

The overall survival (OS) hazard ratio (HR) in the HARMONi trial was 0.78, with a nominal p-value of 0.0332 In the North American patients, the OS HR was 0.70 The HARMONi trial has already ...

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. The Trump administration has vowed to go after anyone who got ...